Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Welldoc Brings AI-Powered Cardiometabolic Care to 68 Million Medicare Beneficiaries Through the ACCESS Model and Medicare App Library
-
RockBreaks – G Mining Ventures Corp. (TSX: GMIN) (OTCQX: GMINF) Reports Q1 2026 Gold Production of 31,846 Ounces
-
Pegasus Tech Ventures and Japanet Expand Corporate Venture Capital (CVC) Fund to US$200 Million
-
Bonaventure Closes on Royal Pointe Apartments in Virginia Beach, Expanding Multifamily Value-Add Portfolio
-
Bitwarden Access Intelligence Introduces Reporting for Risk Over Time to Help Organizations Measure and Reduce Credential Exposure
-
Progress Software Releases 2025 Corporate Social Responsibility Report, Underscoring Global Commitment to Giving Back
-
Consumer Support for AI in P&C Insurance Nearly Doubles in 2026, Insurity Survey Finds
-
DISQO Names Terri Walter Chief Marketing Officer
-
Tenarai Appoints Shashank Samant to its Board of Directors
-
ACTG Launches Critical Study Evaluating Hormone Therapy for Women Living with HIV in the Menopause Transition
-
iA Financial Group Announces Date of 2026 First Quarter Earnings Results and Annual Meeting
-
Cellectar Biosciences Announces Subset of CLOVER WaM Clinical Trial Data Accepted for Presentation at the American Society of Clinical Oncology Conference 2026
-
DLP Capital Appoints Eli Marshall to Lead Strategic Relationships and Organizational Growth
-
Panasonic Unveils New LUMIX S 40mm f/2 Lens for Everyday Shooting; More Info at B&H
-
ROBERTSON STEPHENS NAMED TO USA TODAY’S BEST FINANCIAL ADVISORY FIRMS FOR FOURTH CONSECUTIVE YEAR
-
Tom Depping and LKCM Headwater Investments Reunite to Launch Fox Ridge Capital to Reimagine Access to Business Capital
-
Qualifacts Showcases AI Innovations, Interoperability, and Data Advancements at NatCon26
-
Standard Premium to Present Strategic Priorities and Growth Trajectory at 2026 Annual Shareholders Meeting
-
Disc Medicine Announces Oral Presentation of Data from RALLY-MF Phase 2 Trial of DISC-0974 in Patients with Myelofibrosis and Anemia at the American Society of Clinical Oncology (ASCO) Annual Meeting
-
iLeads Launches AI-Powered Lead Classification Model, Delivering Up to 3X Net Revenue for Mortgage Lenders
-
NAR Pending Home Sales Report Shows 1.5% Increase in March
-
Step Inside: Third Annual Living by Design Virtual Showhouse Now Open
-
Dewpoint Therapeutics Reports Preclinical Data on Oral MYC Condensate Modulator at AACR 2026
-
SourceRE and Hive MLS Catch Major Vendors Circumventing MLS in Groundbreaking Forensic Pilot
-
Concerned About Supporting Erectile Health? Life Extension Launches New Men’s Sexual Health Supplement
-
ImPact Biotech Announces Upcoming Data Presentations for Padeliporfin VTP at AUA and ASCO 2026
-
Wesco Anixter Donates Cable to Support Hands-On Electrical Training at Local College
-
phData Achieves AWS Premier Tier Services Partner Status
-
Environmental Health & Engineering Names New CEO
-
Moderna Announces Data to be Presented at 2026 ASCO Annual Meeting
-
UBS Advisor Peter B. Martin Named to Forbes Best-in-State Wealth Advisors
-
FDA Approves Expanded Clinical Applications for SINEFIX™ in Soft Tissue Repair
-
CURVE Sports Expands Platform with Power Baseball, Strengthening Player Development in Florida
-
TexBuy Purchasing Awards Gordian’s Job Order Contracts to Newly Selected Contractors Across Texas
-
Vonage and Girls Who Code Partner to Enable the Next Generation of Developers
-
Annual general meeting of AB SKF
-
ECD Showcases Its Craftsmanship Capability with Its First 1972 Chevy K5 Blazer Commission for Collector
-
Changes to the Volvo Group Executive Board and Mack Trucks management team
-
MiningNewsBreaks – MAX Power Mining Corp. (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) Expands Lawson Discovery With 3D Seismic Results
-
Leads Biolabs' PD-L1/4-1BB Bispecific Antibody Opamtistomig (LBL-024) Enters Phase Ⅱ Trial with First Patient Dosing in Gastric Cancer, Pioneering Enhanced Immunotherapy Combination Strategies
-
Leads Biolabs' PD-L1/4-1BB Bispecific Antibody Opamtistomig (LBL-024) Enters Phase Ⅱ Trial with First Patient Dosing in Gastric Cancer, Pioneering Enhanced Immunotherapy Combination Strategies
-
TCL Industries Hosts 2026 Global Partners Conference, Unveiling its Latest Roadmap and Innovation Strategy Amid Strong Growth
-
New Charter Technologies Expands with ICG to Advance AI, Security, and Cloud Capabilities for SMB Clients
-
ODIN Consolidates Under Unified Master Brand to Support Global Expat Growth
-
Suvoda announces agentic RTSM, enabling the reduction of clinical trial startup timelines by up to 80%
-
Puppies and Pilates Unveils Its Experience With Immediate Positive Reception Across DC Metro
-
World Insurance Associates Names John Newell as Chief Executive Officer; Founder Rich Eknoian New Executive Chairman
-
$11.8M Verdict Against LAPD Signals Breaking Point for "Less-Lethal" Crowd-Control Tactics
-
HackerOne Introduces h1 Validation to Help Enterprises Manage Surge in AI-Discovered Vulnerabilities
-
CBS Sunday Morning Exposes Deadly Trucking Tragedy: Illegally-Operated Semitrailer Killed Entire Family on Christmas Eve Day, With A Non-English-Speaking Driver Hauling a C.H. Robinson Load

